Panbela Therapeutics (PBLA) has released an update.
After completing its offering and issuing new common stock from the exercised pre-funded warrants, the company had 3,481,298 shares of common stock issued and outstanding as of January 31, 2024.
For further insights into PBLA stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
